Esfazh

Esfazh

Has a normalizing effect on the metabolism of lipids and proteins; on the detoxification function of the liver; to restore and preserve the cellular structure of the liver and phospholipid-dependent enzyme systems; which ultimately prevents the formation of connective tissue in the liver.

Manual

each ampoule contains:

  • Essential phospholipids 250 mg;
  • Benzyl alcohol BP 45 mg (as preservative);
  • Water for injection BP q.s.
  • fatty liver degeneration (including diabetes mellitus);
  • acute and chronic hepatitis;
  • cirrhosis of the liver;
  • liver cell necrosis;
  • hepatic coma and precoma;
  • toxic liver damage;
  • toxicosis of pregnancy;
  • pre- and postoperative treatment, especially during operations in the hepatobiliary zone;
  • psoriasis;
  • radiation syndrome.

The drug is intended for intravenous administration; it should not be administered intramuscularly due to possible local irritation reactions. In the absence of other doctor’s recommendations, the drug should be administered slowly intravenously 1-2 ampoules (5-10 ml) or in severe cases 2-4 ampoules (10-20 ml) per day.

The contents of two ampoules can be administered simultaneously. Do not mix with other medications in the same syringe. It is recommended to dilute the solution with the patient’s blood in a 1:1 ratio.

If it is necessary to dilute the drug, only 5% or 10% dextrose solution is used for infusion administration, and the diluted drug solution must remain clear throughout the entire administration.

Do not dilute the drug with electrolyte solutions (isotonic solution, Ringer’s solution)! It is recommended to supplement parenteral administration with oral administration of the drug as soon as possible.